Showing results (91-100 of 801) with videos related to

Sort By:
Pageof 81
Cells|March 14, 2026
Differential Responsiveness of Human Skin Mast Cells to SCF and IL-33: Reduced Reactivity to SCF but Not to IL-33 in the Post-Mitotic PhaseManqiu Jin, Jean Schneikert, Anja Wegner, et al.
Nature Reviews. Drug Discovery|August 1, 2023
Type 2 chronic inflammatory diseases: targets, therapies and unmet needsPavel Kolkhir, Cezmi A Akdis, Mübeccel Akdis, et al.
Allergy|June 2, 2022
The SCF/KIT axis in human mast cells: Capicua acts as potent KIT repressor and ERK predominates PI3KKristin Franke, Marieluise Kirchner, Philipp Mertins, et al.
Cells|December 9, 2023
Synergism between IL-33 and MRGPRX2/FcεRI Is Primarily Due to the Complementation of Signaling Modules, and Only Modestly Supplemented by Prolonged Activation of Selected KinasesKristin Franke, Zhuoran Li, Gürkan Bal, et al.
Experimental Dermatology|June 16, 2010
Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells--drastically reduced levels of tryptase and chymase in mast cell linesSven Guhl, Magda Babina, Angelos Neou, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 24, 2014
Integration of the human dermal mast cell into the organotypic co-culture skin modelJonghui Kim, Sven Guhl, Magda Babina, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2020
Integration of the Human Dermal Mast Cell into the Organotypic Co-culture Skin ModelJonghui Kim, Sven Guhl, Magda Babina, et al.
Bioscience, Biotechnology, and Biochemistry|February 11, 2011
Long-term cultured human skin mast cells are suitable for pharmacological studies of anti-allergic drugs due to high responsiveness to FcεRI cross-linkingSven Guhl, Metin Artuc, Angelos Neou, et al.
Cells|May 13, 2023
Clorfl86/RHEX Is a Negative Regulator of SCF/KIT Signaling in Human Skin Mast CellsKristin Franke, Gürkan Bal, Zhuoran Li, et al.
Trends in Immunology|April 3, 2007
Mast cells--key effector cells in immune responsesMartin Metz, Marcus Maurer
Pageof 81